MedTrace Logo

Zika Case Definition and Surveillance Study

NCT03158233 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2400

Last updated 2022-04-25

No results posted yet for this study

Summary

This prospective, surveillance study will assess the operational Zika virus definition for use in future Zika purified inactivated virus (ZIKV) vaccine efficacy trials in order to identify Zika virus disease (ZVD) cases among the study cohort.

Conditions

  • Zika Virus Disease

Sponsors & Collaborators

  • Sanofi Pasteur, a Sanofi Company

    lead INDUSTRY

Eligibility

Min Age
15 Years
Max Age
40 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-04-29
Primary Completion
2018-12-19
Completion
2018-12-19

Countries

  • Colombia
  • Honduras
  • Mexico
  • Puerto Rico

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03158233 on ClinicalTrials.gov